Publication for MS4A1 and LOC102723407
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| hsa | MS4A1 | membrane spanning 4-domains A1 | 931 | [link] | ||
| hsa | LOC102723407 | immunoglobulin heavy variable 4-38-2-like | 102723407 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 25340015 | 0.95 | B-1 B cells may phagocytose them, which initiates an anti-inflammatory response either in situ or following migration into the gut (i.e., LP or PPs) in which they may produce anti-inflammatory cytokines and secrete IgA and IgM antibodies to enhance immune exclusion and thus prevent bacterial entry. |
| 0.93 | B-1 B cells, both IgT+ and IgM+ head kidney B cells can proliferate rapidly and secrete IgT and IgM, respectively, in response to microbial stimulation. | |
| 27723281 | 0.94 | CD20 cell number as enumerated by flow cytometry was significantly correlated with CD20/CD19 mRNA expression, consistent with the observed decrease in IgG, IgM, and IgA levels and the decreased number of anti-dsDNA antibodies during treatment with tabalumab 11, 12. |
| 31665076 | 0.89 | MS4A1 parameter was neutral, while increased IgA/MS4A1 had a negative effect on survival in the KRASmut subgroup (Additional file 1: Figure S4b). |
The preparation time of this page was 0.0 [sec].
